Understanding the Functional Anatomy of the Frontalis and Glabellar Complex for Optimal Aesthetic Botulinum Toxin Type A Therapy

[1]  Susan C. Taylor,et al.  AbobotulinumtoxinA for Reduction of Glabellar Lines in Patients with Skin of Color: Post Hoc Analysis of Pooled Clinical Trial Data , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[2]  C. Maas,et al.  Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. , 2012, Aesthetic surgery journal.

[3]  G. Monheit,et al.  Consideration of muscle mass in glabellar line treatment with botulinum toxin type A. , 2012, Journal of drugs in dermatology : JDD.

[4]  J. Emer,et al.  Complications of Minimally Invasive Cosmetic Procedures: Prevention and Management , 2012, Journal of cutaneous and aesthetic surgery.

[5]  C. Martins Gomes,et al.  Comparison of four botulinum neurotoxin type A preparations in the treatment of hyperdynamic forehead lines in men: a pilot study. , 2012, Journal of drugs in dermatology : JDD.

[6]  G. Ryb,et al.  Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles. , 2012, Aesthetic surgery journal.

[7]  G. Ablon,et al.  Comparing the clinical attributes of abobotulinumtoxinA and onabotulinumtoxinA utilizing a novel contralateral Frontalis model and the Frontalis Activity Measurement Standard. , 2011, Journal of drugs in dermatology : JDD.

[8]  G. Ablon,et al.  The Frontalis Activity Measurement Standard: a novel contralateral method for assessing botulinum neurotoxin type-A activity. , 2011, Journal of drugs in dermatology : JDD.

[9]  G. Ablon,et al.  Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model. , 2011, The Journal of clinical and aesthetic dermatology.

[10]  C. Manstein,et al.  Comparing clinical efficacy of botox and dysport in a small group of patients. , 2011, Plastic and reconstructive surgery.

[11]  P. Jaen,et al.  International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part II: wrinkles on the middle and lower face, neck and chest , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  P. Jaen,et al.  International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part I: upper facial wrinkles , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  O. Hevia.  Retrospective review of 500 patients treated with abobotulinumtoxinA. , 2010, Journal of drugs in dermatology : JDD.

[14]  P. Toossi,et al.  Supraciliary wrinkles and botulinum toxin A , 2010, Clinical and experimental dermatology.

[15]  S. Amano,et al.  The severity of wrinkling at the forehead is related to the degree of ptosis of the upper eyelid , 2010, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[16]  D. Hexsel,et al.  Practical applications of a new botulinum toxin. , 2010, Journal of drugs in dermatology : JDD.

[17]  N. Lowe,et al.  Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines , 2010, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[18]  G. Monheit,et al.  Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations. , 2010, Journal of drugs in dermatology : JDD.

[19]  J. Carruthers,et al.  A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes. , 2009, Journal of drugs in dermatology : JDD.

[20]  J. Carruthers,et al.  A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy. , 2009, Journal of the American Academy of Dermatology.

[21]  P. Grimes,et al.  A Four‐Month Randomized, Double‐Blind Evaluation of the Efficacy of Botulinum Toxin Type A for the Treatment of Glabellar Lines in Women with Skin Types V and VI , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  J. Carruthers,et al.  Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies–-Consensus Recommendations , 2008, Plastic and reconstructive surgery.

[23]  H. Judodihardjo,et al.  Different formulations of botulinum toxin type A have different migration characteristics: a double‐blind, randomized study , 2008, Journal of cosmetic dermatology.

[24]  K. Boulle,et al.  Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids , 2008 .

[25]  T. Flynn.  Botox in men , 2007, Dermatologic therapy.

[26]  F. Camacho,et al.  A Randomized Double-Blind Study of the Effect of Botox and Dysport/Reloxin on Forehead Wrinkles and Electromyographic Activity , 2007 .

[27]  W. Binder.  Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. , 2006, Archives of facial plastic surgery.

[28]  E. Jouve,et al.  Management of the ageing eyebrow and forehead: an objective dose–response study with botulinum toxin , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  L. Clauser,et al.  Palpebral Ptosis: Clinical Classification, Differential Diagnosis, and Surgical Guidelines: An Overview , 2006, The Journal of craniofacial surgery.

[30]  A. Benedetto.  Botulinum Toxin in Clinical Dermatology , 2006 .

[31]  A. Benedetto,et al.  Measurement of the Anatomic Position of the Corrugator Supercilii , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[32]  J. Carruthers,et al.  Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. , 2004, Plastic and reconstructive surgery.

[33]  C. Troilius.  Subperiosteal brow lifts without fixation. , 2004, Plastic and reconstructive surgery.

[34]  K. Arndt,et al.  Effect of volume and concentration on the diffusion of botulinum exotoxin A. , 2004, Archives of dermatology.

[35]  J. Finsterer.  Ptosis: Causes, Presentation, and Management , 2003, Aesthetic Plastic Surgery.

[36]  J. Carruthers,et al.  A Prospective, Double‐Blind, Randomized, Parallel‐ Group, Dose‐Ranging Study of Botulinum Toxin Type A in Female Subjects With Horizontal Forehead Rhytides , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[37]  M. Lucarelli,et al.  Depressor Supercilii Muscle: Anatomy, Histology, and Cosmetic Implications , 2001, Ophthalmic plastic and reconstructive surgery.

[38]  S. Kabaker,et al.  An anatomical approach to glabellar rhytids. , 1998, Archives of otolaryngology--head & neck surgery.

[39]  D. Hodge,et al.  Results of levator-advancement blepharoptosis repair using a standard protocol: effect of epinephrine-induced eyelid position change. , 1996, Transactions of the American Ophthalmological Society.

[40]  F. Lepore.  Unilateral ptosis and Hering's law , 1988, Neurology.